Cancer molecular targets and therapeutics. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Cell Line Tumor Cells, Cultured Neoplastic Stem Cells Cells, Cultured HCT116 Cells HT29 Cells Breast HEK293 Cells Epithelial Cells Prostate MCF-7 Cells

Organisms6

Mice, Nude Mice, SCID Mice, Inbred C57BL Mice, Inbred BALB C Mice, Transgenic Mice, Knockout

Diseases43

Breast Neoplasms Neoplasms Prostatic Neoplasms Lung Neoplasms Ovarian Neoplasms Colonic Neoplasms Neoplasm Invasiveness Neoplasm Metastasis Stomach Neoplasms Pancreatic Neoplasms Disease Progression Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Genetic Predisposition to Disease Disease Models, Animal Carcinoma Cell Transformation, Neoplastic Colorectal Neoplasms Uterine Cervical Neoplasms Neovascularization, Pathologic Urinary Bladder Neoplasms Adenocarcinoma Liver Neoplasms Rectal Neoplasms Head and Neck Neoplasms Neoplasm Recurrence, Local Endometrial Neoplasms Neoplasms, Hormone-Dependent Esophageal Neoplasms Mouth Neoplasms Melanoma Skin Neoplasms Gastrointestinal Neoplasms Mammary Neoplasms, Experimental Kidney Neoplasms Neoplasms, Glandular and Epithelial Carcinoma, Small Cell Bone Neoplasms Brain Neoplasms Neoplasms, Radiation-Induced Thyroid Neoplasms Neoplasms, Experimental Neoplasms, Second Primary

Chemicals and Drugs70

Receptor, erbB-2 Receptors, Estrogen Receptors, Progesterone Tumor Markers, Biological Antineoplastic Agents RNA, Small Interfering Neoplasm Proteins RNA, Messenger Cancer Vaccines Anticarcinogenic Agents Protein Kinase Inhibitors Enzyme Inhibitors Antibodies, Monoclonal Tumor Suppressor Protein p53 Antineoplastic Agents, Phytogenic Receptor, Epidermal Growth Factor MicroRNAs Small Molecule Libraries DNA, Neoplasm Transcription Factors Proto-Oncogene Proteins c-akt DNA-Binding Proteins Antigens, Neoplasm Tumor Suppressor Proteins Cisplatin Prostate-Specific Antigen Protein-Serine-Threonine Kinases Paclitaxel Nuclear Proteins Proto-Oncogene Proteins Tamoxifen Fluorouracil Peptides Antibodies, Monoclonal, Humanized Membrane Proteins DNA Primers NF-kappa B Quinazolines Drugs, Investigational Ligands RNA, Neoplasm Indoles Oligonucleotides, Antisense Curcumin Antineoplastic Agents, Hormonal beta Catenin TOR Serine-Threonine Kinases Catechin Recombinant Proteins Proto-Oncogene Proteins c-bcl-2 Aptamers, Nucleotide Taxoids Vascular Endothelial Growth Factor A Drug Carriers Antibiotics, Antineoplastic Carrier Proteins Phosphatidylinositol 3-Kinases Proteins Histone Deacetylase Inhibitors Carcinogens Inhibitor of Apoptosis Proteins Cyclooxygenase 2 Plant Extracts Estrogens Stilbenes Cell Cycle Proteins Biological Products ras Proteins Antimetabolites, Antineoplastic Estrogen Receptor alpha

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

Gene Expression Profiling Early Detection of Cancer Molecular Targeted Therapy Therapeutics Drug Delivery Systems Drug Design Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Clinical Trials as Topic Drug Screening Assays, Antitumor Prognosis Models, Biological Oligonucleotide Array Sequence Analysis Survival Analysis Neoplasm Transplantation Drug Discovery Disease Models, Animal Antineoplastic Combined Chemotherapy Protocols Drug Evaluation, Preclinical Transfection Survival Rate Transplantation, Heterologous Neoplasm Staging Gene Knockdown Techniques Risk Retrospective Studies Combined Modality Therapy Follow-Up Studies Registries Prospective Studies Immunohistochemistry Disease-Free Survival Risk Assessment Tumor Burden Polymerase Chain Reaction Inhibitory Concentration 50 Flow Cytometry Immunotherapy Individualized Medicine Sensitivity and Specificity Odds Ratio Chemoprevention Reproducibility of Results Kaplan-Meier Estimate Chemotherapy, Adjuvant Tissue Array Analysis Real-Time Polymerase Chain Reaction Models, Molecular Risk Factors Treatment Outcome Questionnaires Mammography Immunoenzyme Techniques Multivariate Analysis Predictive Value of Tests Mammary Neoplasms, Experimental SEER Program High-Throughput Screening Assays Drug Carriers Molecular Imaging Genetic Therapy Neoplasms, Experimental Immunoblotting Diagnostic Imaging Cluster Analysis Logistic Models

Psychiatry and Psychology1

Phenomena and Processes50

Gene Expression Regulation, Neoplastic Signal Transduction Apoptosis Cell Proliferation Drug Resistance, Neoplasm Mutation Cell Survival Dose-Response Relationship, Drug RNA Interference Genetic Predisposition to Disease Down-Regulation Cell Cycle Transfection Cell Movement Protein Binding Cell Growth Processes Up-Regulation Cell Division Phosphorylation Risk Gene Silencing Gene Expression Promoter Regions, Genetic DNA Methylation Base Sequence Amino Acid Sequence Inhibitory Concentration 50 Sensitivity and Specificity Genotype Phenotype Odds Ratio Genes, Tumor Suppressor Genes, Neoplasm Transcription, Genetic Drug Synergism Gene Expression Regulation Time Factors Enzyme Activation Genes, BRCA1 Polymorphism, Genetic Binding Sites Cell Death Epigenesis, Genetic Molecular Structure Protein Structure, Tertiary DNA Damage Diet Structure-Activity Relationship Cell Differentiation Genetic Vectors

Disciplines and Occupations8

Drug Design Drug Discovery Medical Oncology Pharmacology, Clinical Immunohistochemistry Individualized Medicine Proteomics Nanomedicine

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture2

Nanoparticles Nanomedicine

Information Science7

Molecular Sequence Data Survival Rate Registries Base Sequence Amino Acid Sequence Questionnaires SEER Program

Named Groups1

Health Care26

Pharmacy and Therapeutics Committee Clinical Trials as Topic Survival Analysis National Cancer Institute (U.S.)Survival Rate Risk Retrospective Studies Follow-Up Studies Registries Prospective Studies Disease-Free Survival Risk Assessment Sensitivity and Specificity Age Factors Odds Ratio Reproducibility of Results Kaplan-Meier Estimate Risk Factors Treatment Outcome Questionnaires Multivariate Analysis Predictive Value of Tests SEER Program American Cancer Society Cluster Analysis Logistic Models

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Breast Neoplasms Neoplasms Receptor, erbB-2 Receptors, Estrogen Receptors, Progesterone Gene Expression Profiling Tumor Markers, Biological Early Detection of Cancer Cell Line, Tumor Antineoplastic Agents Molecular Targeted Therapy Prostatic Neoplasms Therapeutics Gene Expression Regulation, Neoplastic Lung Neoplasms Mice, Nude Drug Delivery Systems Ovarian Neoplasms Signal Transduction Colonic Neoplasms Neoplasm Invasiveness Neoplasm Metastasis RNA, Small Interfering Stomach Neoplasms Neoplasm Proteins Pancreatic Neoplasms Drug Design Xenograft Model Antitumor Assays Apoptosis Cell Proliferation Reverse Transcriptase Polymerase Chain Reaction Drug Resistance, Neoplasm Blotting, Western Mutation RNA, Messenger Pharmacy and Therapeutics Committee Clinical Trials as Topic Drug Screening Assays, Antitumor Cell Survival Cancer Vaccines Disease Progression Prognosis Dose-Response Relationship, Drug Models, Biological RNA Interference Oligonucleotide Array Sequence Analysis Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Survival Analysis Neoplasm Transplantation Anticarcinogenic Agents Genetic Predisposition to Disease Drug Discovery Down-Regulation Disease Models, Animal Protein Kinase Inhibitors Molecular Sequence Data Antineoplastic Combined Chemotherapy Protocols Drug Evaluation, Preclinical Carcinoma Cell Transformation, Neoplastic Enzyme Inhibitors Antibodies, Monoclonal Colorectal Neoplasms Cell Cycle Transfection Tumor Suppressor Protein p53 National Cancer Institute (U.S.)Uterine Cervical Neoplasms Neovascularization, Pathologic Survival Rate Cell Movement Cell Line Transplantation, Heterologous Antineoplastic Agents, Phytogenic Tumor Cells, Cultured Protein Binding Cell Growth Processes Up-Regulation Urinary Bladder Neoplasms Medical Oncology Receptor, Epidermal Growth Factor Pharmacology, Clinical Cell Division Neoplasm Staging Phosphorylation Gene Knockdown Techniques Risk MicroRNAs United States Small Molecule Libraries Gene Silencing Retrospective Studies Combined Modality Therapy Follow-Up Studies Neoplastic Stem Cells Gene Expression Mice, SCID DNA, Neoplasm Mice, Inbred C57BL

No FAQ available that match "cancer molecular targets and therapeutics"